Insider · CIK 0001775394

Funtleyder Leslie D.

CIK 0001775394 Name as filed on the most recent filing

Filed as Funtleyder Leslie D. (13)

37 transaction lines · from 13 filings · filed 2020-06-01 to 2025-03-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

37 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2025-03-04 Applied Therapeutics, Inc.
APLT
S, Open-market sale 14,502 disposed 0.44 6,380.88 Form 4, filing 0000950170-25-035041
2025-02-06 Applied Therapeutics, Inc.
APLT
S, Open-market sale 22,950 disposed 0.61 13,999.50 Form 4, filing 0000950170-25-016588
2024-08-22 Applied Therapeutics, Inc.
APLT
S, Open-market sale 13,530 disposed 5.83 78,879.90 Form 4, filing 0000950170-24-100222
2024-06-06 Applied Therapeutics, Inc.
APLT
S, Open-market sale 16,980 disposed 4.32 73,353.60 Form 4, filing 0000950170-24-071325
2024-03-14 Applied Therapeutics, Inc.
APLT
S, Open-market sale 28,727 disposed 5.39 154,838.53 Form 4, filing 0001096906-24-000491
2020-10-02 Applied Therapeutics Inc.
APLT
S, Open-market sale 5,976 disposed 20.07 119,938.32 Form 4, filing 0001209191-20-053946
2020-10-01 Applied Therapeutics Inc.
APLT
S, Open-market sale 22,671 disposed 20.03 454,100.13 Form 4, filing 0001209191-20-053946
2020-10-01 Applied Therapeutics Inc.
APLT
S, Open-market sale 1,353 disposed 20.75 28,074.75 Form 4, filing 0001209191-20-053946
2020-08-24 Applied Therapeutics Inc.
APLT
S, Open-market sale 13,539 disposed 23.42 317,083.38 Form 4, filing 0001209191-20-048318
2020-08-24 Applied Therapeutics Inc.
APLT
S, Open-market sale 6,461 acquired 24.18 156,226.98 Form 4, filing 0001209191-20-048318
2020-06-25 Applied Therapeutics Inc.
APLT
S, Open-market sale 517 disposed 37.52 19,397.84 Form 4, filing 0001209191-20-039034
2020-06-25 Applied Therapeutics Inc.
APLT
S, Open-market sale 200 disposed 36.12 7,224.00 Form 4, filing 0001209191-20-039034
2020-06-25 Applied Therapeutics Inc.
APLT
S, Open-market sale 100 disposed 38.28 3,828.00 Form 4, filing 0001209191-20-039034
2020-06-24 Applied Therapeutics Inc.
APLT
S, Open-market sale 3,811 disposed 40.41 154,002.51 Form 4, filing 0001209191-20-039034
2020-06-24 Applied Therapeutics Inc.
APLT
S, Open-market sale 3,572 disposed 39.20 140,022.40 Form 4, filing 0001209191-20-039034
2020-06-24 Applied Therapeutics Inc.
APLT
S, Open-market sale 400 disposed 40.92 16,368.00 Form 4, filing 0001209191-20-039034
2020-06-23 Applied Therapeutics Inc.
APLT
S, Open-market sale 4,629 disposed 43.32 200,528.28 Form 4, filing 0001209191-20-039034
2020-06-23 Applied Therapeutics Inc.
APLT
S, Open-market sale 3,462 disposed 44.54 154,197.48 Form 4, filing 0001209191-20-039034
2020-06-23 Applied Therapeutics Inc.
APLT
S, Open-market sale 1,809 disposed 45.35 82,038.15 Form 4, filing 0001209191-20-039034
2020-06-23 Applied Therapeutics Inc.
APLT
S, Open-market sale 1,340 disposed 47.40 63,516.00 Form 4, filing 0001209191-20-039034
2020-06-23 Applied Therapeutics Inc.
APLT
S, Open-market sale 160 disposed 46.45 7,432.00 Form 4, filing 0001209191-20-039034
2020-06-18 Applied Therapeutics Inc.
APLT
S, Open-market sale 7,487 disposed 45.32 339,310.84 Form 4, filing 0001209191-20-038359
2020-06-18 Applied Therapeutics Inc.
APLT
S, Open-market sale 11 disposed 45.90 504.90 Form 4, filing 0001209191-20-038359
2020-06-17 Applied Therapeutics Inc.
APLT
S, Open-market sale 4,100 disposed 44.15 181,015.00 Form 4, filing 0001209191-20-037485
2020-06-16 Applied Therapeutics Inc.
APLT
S, Open-market sale 5,302 disposed 44.37 235,249.74 Form 4, filing 0001209191-20-037485
2020-06-16 Applied Therapeutics Inc.
APLT
S, Open-market sale 100 disposed 45.18 4,518.00 Form 4, filing 0001209191-20-037485
2020-06-10 Applied Therapeutics Inc.
APLT
S, Open-market sale 2,622 disposed 41.80 109,599.60 Form 4, filing 0001209191-20-035769
2020-06-10 Applied Therapeutics Inc.
APLT
S, Open-market sale 2,563 disposed 42.83 109,773.29 Form 4, filing 0001209191-20-035769
2020-06-09 Applied Therapeutics Inc.
APLT
S, Open-market sale 2,000 disposed 42.82 85,640.00 Form 4, filing 0001209191-20-035769
2020-06-09 Applied Therapeutics Inc.
APLT
S, Open-market sale 1,500 disposed 44.87 67,305.00 Form 4, filing 0001209191-20-035769
2020-06-08 Applied Therapeutics Inc.
APLT
S, Open-market sale 8,315 disposed 44.77 372,262.55 Form 4, filing 0001209191-20-035769
2020-06-04 Applied Therapeutics Inc.
APLT
S, Open-market sale 1,482 disposed 44.17 65,459.94 Form 4, filing 0001209191-20-034593
2020-06-03 Applied Therapeutics Inc.
APLT
S, Open-market sale 1,032 disposed 44.03 45,438.96 Form 4, filing 0001209191-20-034593
2020-06-02 Applied Therapeutics Inc.
APLT
S, Open-market sale 12,486 disposed 45.21 564,492.06 Form 4, filing 0001209191-20-034593
2020-05-29 Applied Therapeutics Inc.
APLT
S, Open-market sale 8,495 disposed 45.08 382,954.60 Form 4, filing 0001209191-20-033313
2020-05-29 Applied Therapeutics Inc.
APLT
S, Open-market sale 7,120 disposed 44.27 315,202.40 Form 4, filing 0001209191-20-033313
2020-05-28 Applied Therapeutics Inc.
APLT
S, Open-market sale 2,838 disposed 48.27 136,990.26 Form 4, filing 0001209191-20-033313

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 37
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Funtleyder Leslie D., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001775394

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.